Revenue Summary of PharmaEngine, Inc.

PharmaEngine, Inc.'s latest annual revenue in 2023 was 767.66 Million TWD , up 17.31% from previous year.
PharmaEngine, Inc.'s latest quarterly revenue in 2024 Q2 was 261.9 Million TWD , up 59.24% from previous quarter.
PharmaEngine, Inc. reported a annual revenue of 654.38 Million TWD in annual revenue 2022, down -0.07% from previous year.
PharmaEngine, Inc. reported a annual revenue of 654.83 Million TWD in annual revenue 2021, down -37.99% from previous year.
PharmaEngine, Inc. reported a quarterly revenue of 164.47 Million TWD for 2024 Q1, down -12.2% from previous quarter.
PharmaEngine, Inc. reported a quarterly revenue of 245.94 Million TWD for 2023 Q3, up 48.1% from previous quarter.

Annual Revenue Chart of PharmaEngine, Inc. (2023 - 2009)

Historical Annual Revenue of PharmaEngine, Inc. (2023 - 2009)

Year	Revenue	Revenue Growth
2023	767.66 Million TWD	17.31%
2022	654.38 Million TWD	-0.07%
2021	654.83 Million TWD	-37.99%
2020	1.05 Billion TWD	236.27%
2019	314.04 Million TWD	7.02%
2018	293.43 Million TWD	-65.63%
2017	853.67 Million TWD	-24.77%
2016	1.13 Billion TWD	123.72%
2015	507.24 Million TWD	121.52%
2014	228.98 Million TWD	512.26%
2013	37.4 Million TWD	-79.68%
2012	184.02 Million TWD	-42.5%
2011	320.05 Million TWD	0.0%
2010	- TWD	0.0%
2009	- TWD	0.0%

Year	Revenue	Revenue Growth
2024 Q2	261.9 Million TWD	59.24%
2024 Q1	164.47 Million TWD	-12.2%
2023 Q3	245.94 Million TWD	48.1%
2023 Q4	187.32 Million TWD	-23.83%
2023 FY	767.66 Million TWD	17.31%
2023 Q1	168.33 Million TWD	6.22%
2023 Q2	166.07 Million TWD	-1.34%
2022 Q1	174.12 Million TWD	-14.56%
2022 Q2	166.89 Million TWD	-4.15%
2022 Q3	154.88 Million TWD	-7.2%
2022 Q4	158.47 Million TWD	2.32%
2022 FY	654.38 Million TWD	-0.07%
2021 Q1	115.64 Million TWD	-85.3%
2021 Q2	158.26 Million TWD	36.85%
2021 Q3	177.12 Million TWD	11.92%
2021 Q4	203.8 Million TWD	15.06%
2021 FY	654.83 Million TWD	-37.99%
2020 Q3	95.66 Million TWD	6.14%
2020 Q2	90.13 Million TWD	7.64%
2020 FY	1.05 Billion TWD	236.27%
2020 Q1	83.74 Million TWD	11.76%
2020 Q4	786.46 Million TWD	722.08%
2019 Q3	81.57 Million TWD	2.43%
2019 FY	314.04 Million TWD	7.02%
2019 Q4	74.92 Million TWD	-8.14%
2019 Q2	79.63 Million TWD	2.22%
2019 Q1	77.9 Million TWD	-0.5%
2018 Q2	42.24 Million TWD	24.95%
2018 Q3	139.08 Million TWD	229.24%
2018 FY	293.43 Million TWD	-65.63%
2018 Q4	78.29 Million TWD	-43.7%
2018 Q1	33.8 Million TWD	-95.69%
2017 Q1	10.95 Million TWD	-98.64%
2017 Q3	28.99 Million TWD	-0.52%
2017 Q2	29.14 Million TWD	166.16%
2017 Q4	784.59 Million TWD	2606.23%
2017 FY	853.67 Million TWD	-24.77%
2016 FY	1.13 Billion TWD	123.72%
2016 Q4	805.93 Million TWD	28859.18%
2016 Q3	2.78 Million TWD	-99.14%
2016 Q2	324.47 Million TWD	20358.95%
2016 Q1	1.58 Million TWD	7.53%
2015 FY	507.24 Million TWD	121.52%
2015 Q4	1.47 Million TWD	-45.61%
2015 Q3	2.71 Million TWD	-99.45%
2015 Q2	496.66 Million TWD	7670.1%
2015 Q1	6.39 Million TWD	12.57%
2014 Q3	214.79 Million TWD	5133.82%
2014 Q2	4.1 Million TWD	-6.9%
2014 Q1	4.4 Million TWD	-58.0%
2014 FY	228.98 Million TWD	512.26%
2014 Q4	5.67 Million TWD	-97.36%
2013 Q3	9.09 Million TWD	-6.84%
2013 Q1	8.05 Million TWD	-19.44%
2013 Q2	9.75 Million TWD	21.14%
2013 Q4	10.49 Million TWD	15.45%
2013 FY	37.4 Million TWD	-79.68%
2012 Q3	8.04 Million TWD	-8.52%
2012 Q4	9.99 Million TWD	24.23%
2012 Q2	8.79 Million TWD	-94.4%
2012 FY	184.02 Million TWD	-42.5%
2012 Q1	157.17 Million TWD	720.82%
2011 Q2	285.7 Million TWD	0.0%
2011 FY	320.05 Million TWD	0.0%
2011 Q4	19.14 Million TWD	25.95%
2011 Q1	- TWD	0.0%
2011 Q3	15.2 Million TWD	-94.68%
2010 FY	- TWD	0.0%
2009 FY	- TWD	0.0%

Peer Revenue Comparison of PharmaEngine, Inc.

Name	Revenue	Revenue Difference
SYN-TECH Chem. & Pharm. Co., Ltd.	1.11 Billion TWD	31.131%
Level Biotechnology Inc.	660.61 Million TWD	-16.206%
Sagittarius Life Science Corp	440.46 Million TWD	-74.288%
NeoCore Technology Co., Ltd.	64.72 Million TWD	-1085.974%
TaiMed Biologics Inc.	491.77 Million TWD	-56.101%
GlycoNex Incorporation	2.54 Million TWD	-30099.41%
VBI	55.85 Million TWD	-1274.445%
GeneReach Biotechnology Corp.	225.46 Million TWD	-240.49%
Taiwan Advance Bio-Pharmaceutical Inc.	315.98 Million TWD	-142.946%
Visgeneer Inc.	147.99 Million TWD	-418.716%
Mycenax Biotech Inc.	652.62 Million TWD	-17.629%
Sunmax Biotechnology Co., Ltd.	1.68 Billion TWD	54.549%
G&E Herbal Biotechnology Co., Ltd.	181.44 Million TWD	-323.091%
Medigen Vaccine Biologics Corporation	389.62 Million TWD	-97.028%
TaiwanJ Pharmaceuticals Co., Ltd.	22.74 Million TWD	-3275.556%
Enimmune corporation	43.49 Million TWD	-1665.0%
TaiRx, Inc.	5.08 Million TWD	-15005.647%
CHO Pharma, Inc.	- TWD	-Infinity%
EirGenix Inc.	1.02 Billion TWD	24.934%
BioLASCO Taiwan Co., Ltd.	264.72 Million TWD	-189.99%
Sunny Pharmtech Inc.	428.82 Million TWD	-79.016%
Lin BioScience, Inc.	- TWD	-Infinity%
BioGend Therapeutics Co., Ltd.	109.9 Million TWD	-598.465%
Feng Chi Biotech Corp.	180.57 Million TWD	-325.118%
Bio Preventive Medicine Corp.	1.2 Million TWD	-63448.758%
Lukas Biomedical Inc.	231.83 Million TWD	-231.13%
RBC Bioscience Corporation	172.46 Million TWD	-345.111%
BiOptic Inc.	228.26 Million TWD	-236.3%
BRIM Biotechnology, Inc.	90 Thousand TWD	-852865.556%
Shine-On BioMedical Co.,Ltd.	9.52 Million TWD	-7960.363%
Great Novel Therapeutics Biotech & Medicals	4.85 Million TWD	-15728.227%
Syngen Biotech Co.,Ltd.	1.83 Billion TWD	58.215%
Anti-Microbial Savior BioteQ Co., Ltd	728 Thousand TWD	-105349.038%
SynCore Biotechnology Co.,Ltd	20.19 Million TWD	-3701.094%
Genomics BioSci & Tech. Co.,Ltd.	396.14 Million TWD	-93.786%
Neith Corporation	39.9 Million TWD	-1823.838%
Advagene Biopharma Co., Ltd.	- TWD	-Infinity%
NaviFUS Corp.	22.48 Million TWD	-3314.746%
Gwo Xi Stem Cell Applied Technology Co. , Ltd	141.17 Million TWD	-443.767%
Sinew Pharma Inc.	- TWD	-Infinity%
Andros Pharmaceuticals Co.,Ltd	805 Thousand TWD	-95262.609%
Greenyn Biotechnology Co., Ltd	800.51 Million TWD	4.103%
Lumosa Therapeutics Co., Ltd.	56.91 Million TWD	-1248.775%
AP Biosciences Inc	32.25 Million TWD	-2280.148%
Medigen Biotechnology Corp.	1.15 Billion TWD	33.691%
3D Global Biotech Inc.	20.63 Million TWD	-3620.588%
Pharmosa Biopharm Inc.	314.5 Million TWD	-144.092%
Intech Biopharm Corporation	25.84 Million TWD	-2870.051%
Oneness Biotech Co., Ltd.	86.78 Million TWD	-784.585%
Eusol Biotech Co.,Ltd.	- TWD	-Infinity%
TWi Biotechnology, Inc.	- TWD	-Infinity%
Ever Supreme Bio Technology Co., Ltd	758.39 Million TWD	-1.223%
TCI GENE Inc.	333.85 Million TWD	-129.941%
MegaPro Biomedical Co., Ltd	18 Thousand TWD	-4264727.778%
Senhwa Biosciences, Inc.	1 Million TWD	-76666.9%
Taiwan Bio Therapeutics Co., Ltd	85.47 Million TWD	-798.174%
NatureWise Biotech & Medicals Corporation	160.14 Million TWD	-379.368%
Savior Lifetec Corporation	1.05 Billion TWD	26.908%
TaiGen Biopharmaceuticals Holdings Limited	123.13 Million TWD	-523.442%
OBI Pharma, Inc.	41.54 Million TWD	-1747.623%
Meribank Biotech Co., Ltd	234.34 Million TWD	-227.585%
Acepodia, Inc.	16.59 Million TWD	-4526.463%
Caliway Biopharmaceuticals Co., Ltd.	38.93 Million TWD	-1871.82%

Global Stocks Search

PharmaEngine, Inc. (4162.TWO)

Revenue Summary of PharmaEngine, Inc.

Annual Revenue Chart of PharmaEngine, Inc. (2023 - 2009)

Historical Annual Revenue of PharmaEngine, Inc. (2023 - 2009)

Peer Revenue Comparison of PharmaEngine, Inc.